• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 3MAX SEPARATOR; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 3MAX SEPARATOR; NRY Back to Search Results
Catalog Number 3MAXS
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hemorrhage, Subarachnoid (1893); Perforation of Vessels (2135)
Date of Event 07/08/2012
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Hemorrhage and perforation are known and anticipated complications with these types of procedures and are noted in the device labeling.Therefore, it was determined that the reported subarachnoid hemorrhage and vessel perforation were anticipated procedural complications.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.This report is associated with mfr report numbers: 3005168196-2016-00539, 3005168196-2016-00540, 3005168196-2016-00542, 3005168196-2016-00543, 3005168196-2016-00544.The hospital disposed of the device.
 
Event or Problem Description
The patient underwent a thrombectomy procedure using a penumbra system 5max reperfusion catheter, a penumbra system 3max reperfusion catheter, a penumbra system 3max separator, a px slim delivery microcatheter, a neuron 6f select catheter and a neuron max 6f 088 long sheath.On post-operative day 1 and day 3, a non-contrast computerized tomography (ncct) was performed and revealed evidence of a subarachnoid hemorrhage (sah) in the dorsal insula and hemorrhagic transformation.The sah was noted to be due to vessel perforation.The patient showed overall clinical improvement in neurological status and was maintained on diltiazem and atenolol for atrial fibrillation throughout the hospital stay.On (b)(6) 2012, the patient was subsequently discharged to an acute rehabilitation nursing facility.The sah was reviewed and adjudicated by the committee to be a non-serious adverse event with a possible relationship to the penumbra system and angiographic procedure but unrelated to the index stoke.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 3MAX SEPARATOR
Common Device Name
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key5611970
Report Number3005168196-2016-00541
Device Sequence Number13561044
Product Code NRY
UDI-Device Identifier00814548012483
UDI-Public00814548012483
Combination Product (Y/N)N
Initial Reporter StateIA
PMA/510(K) Number
K133317
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/30/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date10/31/2014
Device Catalogue Number3MAXS
Device Lot NumberF23448
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/30/2016
Initial Report FDA Received Date04/27/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Other;
-
-